Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 406 AL 420

ACAT1 as a Therapeutic Target and its Genetic Relationship with Alzheimer's Disease

Alavez-Rubio JS, Juarez-Cedillo T.

Curr Alzheimer Res. 2019;16(8):699-709. doi: 10.2174/1567205016666190823125245.

Regulation of intrinsic excitability: Roles for learning and memory, aging and Alzheimer's disease, and genetic diversity

Dunn AR, Kaczorowski CC.

Neurobiol Learn Mem. 2019 Oct;164:107069. doi: 10.1016/j.nlm.2019.107069. Epub 2019 Aug 20.

Association between Apolipoprotein E Gene Polymorphism and Alzheimer's Disease in an Iranian Population: A Meta-Analysis

Abyadeh M, Djafarian K, Heydarinejad F, Alizadeh S, Shab-Bidar S.

J Mol Neurosci. 2019 Dec;69(4):557-562. doi: 10.1007/s12031-019-01381-1. Epub 2019 Aug 23.

Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD

Beretta L, Caminiti SP, Santangelo R, Magnani G, Ferrari-Pellegrini F, Caffarra P, Perani D.

Neuropsychologia. 2019 Oct;133:107174. doi: 10.1016/j.neuropsychologia.2019.107174. Epub 2019 Aug 22.

Iron Pathophysiology in Alzheimer's Diseases

Wang T, Xu SF, Fan YG, Li LB, Guo C.

Adv Exp Med Biol. 2019;1173:67-104. doi: 10.1007/978-981-13-9589-5_5.

Neuropeptides in Alzheimer's Disease: An Update

Petrella C, Di Certo MG, Barbato C, Gabanella F, Ralli M, Greco A, Possenti R, Severini C.

Curr Alzheimer Res. 2019;16(6):544-558. doi: 10.2174/1567205016666190503152555.

Nanomedicine for the Treatment of Alzheimer's Disease

Formicola B, Cox A, Dal Magro R, Masserini M, Re F.

J Biomed Nanotechnol. 2019 Oct 1;15(10):1997-2024. doi: 10.1166/jbn.2019.2837.

Validation of a digitally delivered visual paired comparison task: reliability and convergent validity with established cognitive tests

Gills JL, Glenn JM, Madero EN, Bott NT, Gray M.

Geroscience. 2019 Aug;41(4):441-454. doi: 10.1007/s11357-019-00092-0. Epub 2019 Aug 29.

Expanding Alzheimer: a unique FASEB Journal contribution

Pederson T.

FASEB J. 2019 Sep;33(9):9697-9698. doi: 10.1096/fj.190901ufm.

"Muscle-Gut-Brain Axis": Can Physical Activity Help Patients with Alzheimer's Disease Due to Microbiome Modulation?

Schlegel P, Novotny M, Klimova B, Valis M.

J Alzheimers Dis. 2019;71(3):861-878. doi: 10.3233/JAD-190460.

Peripheral blood DNA methylation differences in twin pairs discordant for Alzheimer's disease

Konki M, Malonzo M, Karlsson IK, Lindgren N, Ghimire B, Smolander J, Scheinin NM, Ollikainen M, Laiho A, Elo LL, Lönnberg T, Röyttä M, Pedersen NL, Kaprio J, Lähdesmäki H, Rinne JO, Lund RJ.

Clin Epigenetics. 2019 Sep 2;11(1):130. doi: 10.1186/s13148-019-0729-7.

Neurodegeneration and Neuro-Regeneration-Alzheimer's Disease and Stem Cell Therapy

Vasic V, Barth K, Schmidt MHH.

Int J Mol Sci. 2019 Aug 31;20(17):4272. doi: 10.3390/ijms20174272.

Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles

Singh AK, Mishra G, Maurya A, Awasthi R, Kumari K, Thakur A, Rai A, Rai GK, Sharma B, Kulkarni GT, Singh SK.

Curr Alzheimer Res. 2019;16(13):1216-1229. doi: 10.2174/1567205016666190903102822.

Rebalancing metal dyshomeostasis for Alzheimer's disease therapy

Yang GJ, Liu H, Ma DL, Leung CH.

J Biol Inorg Chem. 2019 Dec;24(8):1159-1170. doi: 10.1007/s00775-019-01712-y. Epub 2019 Sep 5.

[Quo vadis Alzheimer?]

Jessen F, Haass C.

Nervenarzt. 2019 Sep;90(9):881-883. doi: 10.1007/s00115-019-0771-x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias